DMGDH Antibodies

Santa Cruz Biotechnology delivers a wide array of DMGDH monoclonal antibodies for investigating dimethylglycine dehydrogenase (DMGDH) in various biological processes. DMGDH Antibodies targeting DMGDH are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DMGDH is a key enzyme involved in the metabolism of dimethylglycine, playing a crucial role in the conversion of this compound to sarcosine and subsequently to glycine. This metabolic pathway is important for maintaining cellular homeostasis and energy production, and alterations in DMGDH activity have been linked to various metabolic disorders. Understanding the function of DMGDH is essential for elucidating its potential implications in health and disease. Researchers can explore DMGDH's role in metabolic pathways and its impact on cellular function through precise detection methods. DMGDH monoclonal antibodies enable detailed investigation of enzyme distribution, activity, and regulation across different tissue types. Santa Cruz Biotechnology monoclonal antibodies targeting DMGDH support researchers worldwide in advancing our understanding of metabolic processes and potential therapeutic interventions.